Exponential Medicine: SU's Conference Explores Technology's Potential to Reshape Healthcare

November 6, 2017

SAN DIEGO, CA – November 6, 2017 – Singularity University (SU), a global community with a mission to educate, inspire, and empower leaders to apply exponential technologies to address humanity’s grand challenges, today announced its seventh annual Exponential Medicine conference, taking place at the Hotel del Coronado in San Diego, November 6-9, 2017. Over 600 innovators from across the healthcare, technology, biopharma, engaged patient, and investment worlds will join over 70 world-class faculty and 55 innovative startups to explore cutting-edge technology and its potential to reshape health care across the planet.Founded in 2011 by Dr. Daniel Kraft, a Stanford and Harvard trained physician-scientist, and SU’s Faculty Chair of Medicine and Neuroscience, Exponential Medicine is a complete reinvention of the traditional medical conference. At Exponential Medicine, participants learn about, experience, and discuss the current and future implications and impact of fast-evolving and convergent exponential technologies, from artificial intelligence, robotics, and digital health, to regenerative medicine and virtual reality. Over 50 startups will be featured in the Innovation Lab, enabling hands-on technology demonstrations and a startup competition. The Lab, faculty talks, topic tracks, breakout sessions, and demos encourage in-depth discussion and debate.“I designed Exponential Medicine to be at the center of thought leadership and the practical application of these emerging technologies on health care in the next two to 10 years,” said Dr. Kraft. “I’ve seen firsthand how bringing together world-class leaders at Exponential Medicine allows for the sharing of insights leading to breakthroughs and scientific developments that have had significant impact. For four days, we are all inspired to think exponentially and interact with each other with the goal of exploring the latest technology game changers.”“Traditionally, knowledge and health care resources existed in the hands of the few; now, the capacity to create and innovate is in the hands of everyone,” said Asif Dhar, Principal, Deloitte Consulting LLP, and Chief Health Informatics Officer. “From Bangladesh to Boston, technology has the potential to democratize health care. Deloitte is excited to collaborate with SU on this year’s Exponential Medicine conference. We look forward to participating in an event that empowers participants to envision and unlock exponential growth and opportunities across biomedicine.”2017 Exponential Medicine Faculty and topics include:

  • Dr. Daniel Kraft, SU Founder and Chair, Exponential Medicine, Catalyzing the Future of Healthcare
  • Dr. Peter Diamandis, Founder of XPRIZE, Singularity University, Cancer XPRIZE Update
  • Charity Sunshine Tillemann-Dick, Soprano, double lung transplant, Music and Medicine
  • Dr. Richard Wender, Chief Cancer Control Officer, American Cancer Society, Reimagining Cancer from Dx to Rx
  • Ray Kurzweil, Co-founder, Chancellor Singularity University, Forecasting the Future
  • Brian Forde, Director Digital Currency, MIT Media Lab
  • Michael J Gelb, Pioneer in Creative Thinking and Innovation Leadership, How to Think Like Leonardo DaVinci and Innovate Like Edison
  • Asif Dhar, Principal, Deloitte Consulting LLP, and CHIO, Future of the Regulator
  • Bakul Patel, Food and Drug Administration, Future of the Regulator
  • Moira Gunn, PhD, host of NPR’s Biotech Nation

Introduction to Exponentials in Medicine

  • Neil Jacobstein, SU Chair of AI, Robotics, Artificial Intelligence
  • Dr. Catherine Mohr, VP Strategy, Intuitive Surgical, Robotics
  • Dr. John Mattison, Chief Medical Office, Kaiser Permanente, Healthcare IT - Blockchain
  • Raymond McCauley, SU Chair Digital Biology, Digital Biology
  • A. Dara Dotz, Principal Designer, Co-Founder, Field Ready, 3D Printing
  • John S. Brownstein, PhD, Chief Innovation Officer, Boston Children’s Hospital, Big Data and Medicine
  • Naveen Jain, Founder and CEO, Viome, Exponential Entrepreneurship
  • John Werner, VP, Meta, Augmented Reality Technologies
  • Alex Zhavoronkov, PhD, Co-founder and CEO, Insilico Medical

Convergence: Patient, Surgeon, Roboticist

  • Larry Smarr, PhD, UCSD Prof., Director, Calit2
  • Dr. Sonia Ramamoorthy, Prof. of Surgery, Chief Division of Colon & Rectal Surgery, Vice Chair UCSD Cancer Center

Digital, Mobile, Connected Health

  • Dr. Amin Lernan, Mayo Clinic
  • Jeroen Tas, EVP, Philips
  • Jeffrey Brewer, CEO, Bigfoot Biomedical

AI to Intelligence Augmentation

  • Mark Michalski, MD, MGH & BWH Center for Clinical Data Science
  • Rachel Thomas, Founder, Deep Learning Researcher, fast.ai
  • Eyal Gura, Co-Founder and Chairman, Zebra Medical Vision

Regenerative Medicine and Human 2.0

  • Ken Dychtwald, PhD, Founder, CEO AgeWave
  • Dr. Robert Hariri, Co-Founder, President, Human Longevity Cellular Therapeutics
  • Hans Keirstead, PhD, Stem Cell Biologist, Candidate for U.S. Congress
  • Roman Reed, Patient Advocate, Roman Reed Foundation

Future of the Brain and Neuroscience

  • Dr. Divya Chander, Anesthesiologist, Neuroscientist, Stanford
  • Dr. Jordan Amadio, Neuroscience, Resident Physician in Neurosurgery, Emory
  • Yan Fossat, Principal Investigator, Labs for Klick Health
  • Kate Rosenbluth, PhD, CEO, Cala Health

AR/VR and Envisioning the Future of Healthcare

  • Dr. Brennan Spiegel, Director Health Services Research, Cedars-Sinai
  • Nadine Hachach-Haram, NHS Clinical Entrepreneur Fellow, Founder, Proxime
  • Dr. Rafael Grossmann, General, Trauma, Advanced Laparoscopic and Robotic Surgeon
  • Shafi Ahmed, PhD, Co-founder, Virtual Medical and Medical Realities

Advocacy, Media, Medicine

  • Jennifer Brea, Health Activist, Filmmaker, Director of the new movie, Unrest
  • Dr. Andy Kogelnik, Director, Open Medicine Institute

Transforming Mental Health and Wellness

  • Dr. Shanon Jaccard, CEO National Alliance of Mental Illness
  • Margaret Laws CEO Hope Labs

Future of Clinical Practice:The Chatbot Will See You Now

  • Dr. Jordan Shlain, Founder, Private Medical, Founder and Chairman, HealthLoop
  • Dr. Leslie Saxon, Founder, Executive Director, USC Center for Body Computing
  • Dr. Alan Greene, Founder, Dr. Green.com

Hacking Healthcare

  • Anna Young, Co-founder, Pop Up Labs
  • Michael Serres, Patient Voice/Ambassador for the NHS, Founder of 11 Health
  • David Metcalf, PhD, Researcher for the Institute for Simulation and Training, University of Central Florida, President, Moving Knowledge
  • Dr. Chad Ruffin, Ear Surgeon, Research Fellow at Indiana University, CEO Ruff Lab Technologies,cochlear implant recipient

Future of Work

  • Jen Radin, Principal, Deloitte Consulting
  • Anne Gross, CNO, Dana Farber
  • Stephen Hunt, MD, UPenn
  • Ken Abrams, MD, Managing Director, Deloitte Consulting LLP

Social determinants of health and their impact on opioids abuse

  • Josh Lee, Principal, Deloitte Consulting LLP
  • Dr. Gloria Wilder, Chief Executive Officer, Core Health and VP innovation and preventative health, Centene Corporation

Deloitte is the Platinum Sponsor of the Exponential Conference Series, including Exponential Medicine, Exponential Manufacturing, Exponential Finance, the Global Summit, and SingularityU International Summits. Deloitte is also a founding member of SingularityU Netherlands.To learn more about any of the SU programs and events and Deloitte innovation resources, go to www.su.org and https://www2.deloitte.com/us/en/pages/strategy/topics/innovation-consulting.html.ABOUT EXPONENTIAL MEDICINEExponential Medicine is a four-day program exploring the convergence of technology and the potential impact on health and medicine. Follow Exponential Medicine on Twitter @ExponentialMed and the conference via the #xMed hashtag. The conference will be accessible via free livestreaming starting at 1pm PST on Nov 6th, through 1pm on November 9th at http://ExponentialMedicine.com.ABOUT DELOITTEDeloitte provides industry-leading audit, consulting, tax and advisory services to many of the world’s most admired brands, including more than 85 percent of the Fortune 500 and more than 6,000 private and middle market companies. Our people work across more than 20 industry sectors to make an impact that matters — delivering measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to see challenges as opportunities to transform and thrive, and help lead the way toward a stronger economy and a healthy society. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them.Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.ABOUT SINGULARITY UNIVERSITYSingularity University (SU) is a global learning and innovation community using exponential technologies to tackle the world’s biggest challenges and build an abundant future for all. SU's collaborative platform empowers individuals and organizations across the globe to learn, connect, and innovate breakthrough solutions using accelerating technologies like artificial intelligence, robotics, and digital biology. A certified benefit corporation headquartered at NASA Research Park in Silicon Valley, SU was founded in 2008 by renowned innovators Ray Kurzweil and Dr. Peter H. Diamandis with program funding from leading organizations including Google, Deloitte, and UNICEF. To learn more, visit SU.org, join us on Facebook, follow us on Twitter @SingularityU, and download the SingularityU Hub mobile app.MEDIA CONTACTS:Anna Roubos, anna@tablepr.co774-232-2460Jodie Stern, jodiestern@deloitte.com414-702-0167